| 今开：13.46 | 昨收：13.32 |
| 最高：13.83 | 最低：13.16 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.84336412E8 |
Enanta(ENTA)01-27 05:45
$Enanta制药(ENTA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-016774 Act: 34 Size: 321 KB 网页链接查看全文
Enanta(ENTA)02-15 09:05
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003223 Size: 6 KB 网页链接查看全文
Enanta(ENTA)03-09 06:35
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006052 Size: 5 KB 网页链接查看全文
Enanta(ENTA)02-09 19:05
$Enanta制药(ENTA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-000353 Act: 33 Size: 1 KB 网页链接查看全文
Enanta(ENTA)02-15 09:25
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003237 Size: 6 KB 网页链接查看全文
Enanta(ENTA)02-15 09:25
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003233 Size: 7 KB 网页链接查看全文
Enanta(ENTA)02-08 05:15
$Enanta制药(ENTA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-012186 Act: 34 Size: 348 KB 网页链接查看全文
Enanta(ENTA)03-13 04:05
$Enanta制药(ENTA)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0000950170-24-029889 Act: 34 Size: 349 KB 网页链接查看全文
Enanta(ENTA)01-25 06:35
$Enanta制药(ENTA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-002756 Act: 34 Size: 13 KB 网页链接查看全文
Enanta(ENTA)01-27 05:45
$Enanta制药(ENTA)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-016781 Act: 34 Size: 1 MB 网页链接查看全文
智通财经APP获悉，美国生物技术公司Enanta Pharmaceuticals(ENTA.US)表示，其潜在的治疗COVID-19的口服药物EDP-235在临床前研究中显示出抗病毒活性。 该公司表示，在一项生化分析中，EDP-235抑制了SARS-CoV-2 3CLpro蛋白酶，这种活性在S... 网页链接
$Enanta制药(ENTA)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0000950170-24-029889 Act: 34 Size: 349 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006050 Size: 5 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006052 Size: 5 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006038 Size: 5 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006042 Size: 5 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006046 Size: 5 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-006036 Size: 5 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-004659 Size: 7 KB 网页链接
$Enanta制药(ENTA)$ SCHEDULE 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001609251-24-000004 Act: 34 Size: 33 KB 网页链接
$Enanta制药(ENTA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003233 Size: 7 KB 网页链接